{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T18:02:26Z","timestamp":1648836146692},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.31003\/uspnf_m23340_04_01","type":"standard","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T19:24:06Z","timestamp":1636745046000},"source":"Crossref","is-referenced-by-count":0,"title":["Dexamethasone Tablets"],"prefix":"10.31003","member":"14819","container-title":[],"original-title":[],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T19:24:09Z","timestamp":1636745049000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M23340_04_01.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m23340_04_01","relation":{},"subject":[]}}